Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders

Radoslaw Kaczmarek¹, Magdy El Ekiaby^{1

2}, Daniel P Hart^{1

3

4}, Cedric Hermans^{1

5}, Mike Makris^{1

6}, Declan Noone^{1

7}, Brian O'Mahony^{1

8

9}, David Page^{1

10}, Flora Peyvandi^{1

11

12}, Steven W Pipe^{1

13

14}, Thomas Sannié^{1

7

15}, Uwe Schlenkrich^{1

16}, Mark W Skinner^{1

17

18}, Alok Srivastava^{1

19}, Amanda Bok⁷, Glenn F Pierce^{1

20}; World Federation of Hemophilia (WFH), European Association for Haemophilia, Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), U.S. National Hemophilia Foundation (NHF)

Affiliations

¹ Coagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
² Shabrawishi Hospital Blood Transfusion & Hemophilia Treatment Center, Giza, Egypt.
³ The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
⁴ Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
⁵ Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
⁶ Medical Advisory Group, European Haemophilia Consortium, Brussels, Belgium.
⁷ European Haemophilia Consortium, Brussels, Belgium.
⁸ Irish Haemophilia Society, Dublin, Ireland.
⁹ Trinity College, Dublin, Ireland.
¹⁰ Canadian Hemophilia Society, Montreal, Canada.
¹¹ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
¹² Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
¹³ Medical and Scientific Advisory Council, National Hemophilia Foundation, New York, NY, USA.
¹⁴ Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI, USA.
¹⁵ Association Française des Hémophiles, Paris, France.
¹⁶ German Haemophilia Society, Hamburg, Germany.
¹⁷ Institute for Policy Advancement Ltd, Washington, DC, USA.
¹⁸ McMaster University, Hamilton, Ontario, Canada.
¹⁹ Department of Haematology, Christian Medical College, Vellore, India.
²⁰ World Federation of Hemophilia, Montreal, Quebec, Canada.

PMID: 33651911
PMCID: PMC8014441
DOI: 10.1111/hae.14271

Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders

Radoslaw Kaczmarek et al. Haemophilia. 2021 Jul.

. 2021 Jul;27(4):515-518.

doi: 10.1111/hae.14271. Epub 2021 Mar 2.

Authors

Affiliations

¹ Coagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
² Shabrawishi Hospital Blood Transfusion & Hemophilia Treatment Center, Giza, Egypt.
³ The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
⁴ Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
⁵ Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
⁶ Medical Advisory Group, European Haemophilia Consortium, Brussels, Belgium.
⁷ European Haemophilia Consortium, Brussels, Belgium.
⁸ Irish Haemophilia Society, Dublin, Ireland.
⁹ Trinity College, Dublin, Ireland.
¹⁰ Canadian Hemophilia Society, Montreal, Canada.
¹¹ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
¹² Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
¹³ Medical and Scientific Advisory Council, National Hemophilia Foundation, New York, NY, USA.
¹⁴ Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI, USA.
¹⁵ Association Française des Hémophiles, Paris, France.
¹⁶ German Haemophilia Society, Hamburg, Germany.
¹⁷ Institute for Policy Advancement Ltd, Washington, DC, USA.
¹⁸ McMaster University, Hamilton, Ontario, Canada.
¹⁹ Department of Haematology, Christian Medical College, Vellore, India.
²⁰ World Federation of Hemophilia, Montreal, Quebec, Canada.

PMID: 33651911
PMCID: PMC8014441
DOI: 10.1111/hae.14271

No abstract available

PubMed Disclaimer

References

1. Verbeke R, Lentacker I, De Smedt SC, et al. Three decades of messenger RNA vaccine development. Nano Today. 2019;28:100766.
1. Chakraborty R, Parvez S. COVID‐19: an overview of the current pharmacological interventions, vaccines, and clinical trials. Biochem Pharmacol. 2020;180:114184. - PMC - PubMed
1. Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS‐CoV‐2 mRNA‐1273 vaccine in older adults. N Engl J Med. 2020;383:2427‐2438. - PMC - PubMed
1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID‐19 vaccine. N Engl J Med. 2020;NEJMoa2034577. - PMC - PubMed
1. Moderna’s COVID‐19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna, Inc. https://investors.modernatx.com/news‐releases/news‐release‐details/moder...

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders

Affiliations

Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders

Authors

Affiliations

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical